ranQ
ranQ
ranQ
DirectoryIndustriesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint742,806 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryBaselRocketvax AG
Rocketvax AG Logo
Verified· 3 sources

Rocketvax AG

Summary

About the company

The core activity of RocketVax AG is the development and research of vaccines, particularly against Covid-19. The company focuses on developing vaccines that guarantee better immunity and can be easily administered through the nose. It is also working on improving Corona vaccine protection and plans to develop new vaccines.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered4
Development of live-attenuated vaccines
Development of next-generation vaccines based on live-attenuated virus technology for established and new indications, focused on infectious diseases and unmet medical needs.
Development of SARS-CoV-2 vaccine candidates
Development of SARS-CoV-2 vaccine candidates RVX-sCPD9 and RVX-OTS as well as OTS-228, with preclinical data on safety, efficacy, stability and transmission-blocking immunity.
Nasal vaccine development
Development of a needle-free intranasal vaccine candidate against SARS-CoV-2, focused on easy administration, local immunity, reduced transmission and broad variant coverage.
Vaccine platform technology
Rational genetic design and proprietary vaccine platform technology for generating attenuated viruses, described as applicable to coronaviruses, influenza, flaviviruses, pneumoviruses, alphaviruses and herpes.
Press

Media

March 18, 2022Media
Researchers accelerate two SARS-Cov-2 vaccine candidates into clinical trials
startupticker.ch

Knowledge

No knowledge articles yet

Once Rocketvax AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Rocketvax AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Rocketvax AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Rocketvax AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Lautengartenstrasse 6
4052 Basel
Opening hours
Mon
09:00 - 17:00
Tue
09:00 - 17:00
Wed
09:00 - 17:00
Thu
09:00 - 17:00
Fri
09:00 - 17:00
Sat
Closed
Sun
Closed

At a glance

Legal form
Corporation
UID
CHE-204.298.880
Founded
2019 · 7 years
Last commercial register change
July 31, 2026
Employees
21 to 50

Similar companies

TT
TOLREMO therapeutics AG
Basel
MP
Mepha Pharma AG
Basel
ST
Synendos Therapeutics AG
Basel
TT
TargImmune Therapeutics AG
Basel